Olive ( DrugBank: Olive )


3 diseases
告示番号疾患名(ページ内リンク)臨床試験数
13多発性硬化症/視神経脊髄炎3
49全身性エリテマトーデス1
53シェーグレン症候群1

13. 多発性硬化症/視神経脊髄炎


臨床試験数 : 3,342 薬物数 : 2,355 - (DrugBank : 406) / 標的遺伝子数 : 269 - 標的パスウェイ数 : 241
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05007483
(ClinicalTrials.gov)
March 1, 20229/8/2021Efficacy of Diet on Quality of Life in Multiple SclerosisEfficacy of Diet on Quality of Life in Multiple SclerosisMultiple Sclerosis, Relapsing-RemittingDietary Supplement: BodyBio Balance Oil;Dietary Supplement: Kirunal Fish Oil;Dietary Supplement: BodyBio PC;Behavioral: Modified Paleolithic Elimination diet;Behavioral: Time Restricted Olive Oil Based (TROO) Ketogenic Diet;Behavioral: Dietary Guidelines for Americans DietTerry L. WahlsNULLNot yet recruiting18 Years70 YearsAll156N/AUnited States
2NCT04787497
(ClinicalTrials.gov)
December 20211/3/2021The Effect of Extra Virgin Olive Oil in People With Multiple SclerosisThe Neuropsychological Effects of Extra-Virgin Olive Oil in People With Multiple SclerosisMultiple SclerosisDietary Supplement: High Phenolic Extra Virgin Olive OilUniversity of CyprusWorld Olive Center for Health;Ellis-Farm, Eliama Daily ValueNot yet recruiting18 Years65 YearsAll100N/ANULL
3NCT04120675
(ClinicalTrials.gov)
November 9, 201824/9/2019Efficacy of Early Harvest Olive Oil in Cognition of Primary (PPMS) or Secondary (SPMS) Progressive Multiple SclerosisThe Effects of Early Harvest Extra Virgin Olive Oil on Cognition and Mental Health of Primary (PPMS) or Secondary (SPMS) Progressive Multiple Sclerosis PatientsProgressive Multiple SclerosisDietary Supplement: Early Harvest Extra Virgin Olive OilAristotle University Of ThessalonikiGreek Alzheimer's Association and Related Disorders;Ellis-Farm, Eliama Daily Value Gold (ellis-farm.com)Completed18 Years65 YearsAll30N/AGreece

49. 全身性エリテマトーデス


臨床試験数 : 946 薬物数 : 722 - (DrugBank : 186) / 標的遺伝子数 : 117 - 標的パスウェイ数 : 199
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02021513
(ClinicalTrials.gov)
January 201213/12/2013Pilot Study - Effect of Omega-3 on Systemic Lupus ErythematosusPilot Study - Effect of Omega-3 on Systemic Lupus ErythematosusSystemic Lupus ErythematosusDietary Supplement: Fish Oil;Dietary Supplement: Olive OilUniversity of Texas Southwestern Medical CenterNULLCompleted18 Years64 YearsBoth50Phase 2United States

53. シェーグレン症候群


臨床試験数 : 283 薬物数 : 320 - (DrugBank : 101) / 標的遺伝子数 : 56 - 標的パスウェイ数 : 181
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01850979
(ClinicalTrials.gov)
February 20101/5/2013Treatment of Dry Eye Using 0.03% Tacrolimus Eye DropsTreatment of Dry Eye Using 0.03% Tacrolimus Eye Drops: Prospective Double-Blind Randomized StudySjogren Syndrome;Dry Eye SyndromeDrug: Tacrolimus;Drug: Olive OilUniversity of Sao Paulo General HospitalNULLCompleted40 Years60 YearsBoth24Phase 4Brazil